H. Erzigkeit

发表

[MWT-A--a repeatable intelligence short-test, fairly independent from psycho-mental disorders].

S. Lehrl, J. Merz, H. Erzigkeit, 1974, Der Nervenarzt.

Idebenone: a guide to its use in Alzheimer’s disease, other age-related cognitive disorders and Friedreich’s ataxia

I. Deary, A. Gow, S. Noble, 2010 .

Alzheimer's Disease Assessment Scale: Reliability and Validity in a Multicenter Clinical Trial

R. Ihl, S. Kanowski, G. Weyer, 1997, International Psychogeriatrics.

Psychological evaluation of extremely obese patients before and after surgical treatment

H. Erzigkeit, B. Husemann, 1981, World Journal of Surgery.

Donepezilof its Use in Alzheimer's Disease

S. Lovestone, L. Parnetti, H. Erzigkeit, 2000 .

Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes.

I. Hindmarch, H. Erzigkeit, H. Erzigkeit, 1991, International clinical psychopharmacology.

Efficacy and safety of idebenone in the long‐term treatment of Alzheimer's Disease: a double‐blind, placebo controlled multicentre study

G. Weyer, D. Hadler, H. Erzigkeit, 1996 .

[The multiple selection vocabulary test (MSVT-B)--an accelerated intelligence test].

S Lehrl, H Erzigkeit, J Merz, 1975, Psychiatrie, Neurologie, und medizinische Psychologie.

The SKT — A Short Cognitive Performance Test as an Instrument for the Assessment of Clinical Efficacy of Cognition Enhancers

H. Erzigkeit, 1989 .

Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome

H. Erzigkeit, R. Schaltenbrand, L. Blaha, 1989 .